Evaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Cancer

被引:9
|
作者
Karakus, Nevin [1 ]
Kara, Nurten [2 ]
Ulusoy, Ali N. [3 ]
Ozaslan, Cihangir [4 ]
Tural, Sengul [2 ]
Okan, Ismail [5 ]
机构
[1] Gaziosmanpasa Univ, Fac Med, Dept Med Biol, TR-60100 Muhittin Fisunoglu, Tokat, Turkey
[2] Ondokuz Mayis Univ, Fac Med, Dept Med Biol, Samsun, Turkey
[3] Ondokuz Mayis Univ, Fac Med, Dept Gen Surg, Samsun, Turkey
[4] Oncol Res & Training Hosp, Dept Gen Surg, Ankara, Turkey
[5] Gaziosmanpasa Univ, Fac Med, Dept Gen Surg, TR-60100 Muhittin Fisunoglu, Tokat, Turkey
关键词
Breast cancer; Leptin; CYP17A1; Genetic susceptibility; Polymorphism; LIFE-STYLE FACTORS; RISK; ESTROGEN; PROMOTER;
D O I
10.1159/000438940
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Polymorphisms of estrogen synthesis- and adiposity-related genes can contribute to the development of breast cancer. The purpose of the current study was to analyze the association between CYP17A1 T27C (rs743572) and LEP -2548G>A (rs7799039) gene polymorphisms and breast cancer. Material and Methods: 199 breast cancer patients and 197 healthy controls were included in the study. The CYP17A1 and LEP gene polymorphisms were determined using polymerase chain reaction-based restriction fragment length polymorphism analysis. Results: No statistically significant association was found between these polymorphisms and breast cancer risk among a Turkish population. However, stratified analysis of these polymorphisms in relation to different clinicopathological characteristics of breast cancer revealed an association between breast cancer diagnosis and the CYP17A1 T27C polymorphism (p = 0.024). Conclusion: Our study suggests no strong association between the CYP17A1 T27C and LEP -2548G>A polymorphisms and the incidence of breast cancer in Turkish women. The potential association between CYP17A1 T27C and the type of breast cancer deserves further consideration. (C) 2015 S. Karger GmbH, Freiburg
引用
收藏
页码:418 / 422
页数:5
相关论文
共 50 条
  • [21] Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India
    Chattopadhyay, Shilpi
    Siddiqui, Sarah
    Akhtar, Md. Salman
    Najm, Mohammad Zeeshan
    Deo, S. V. S.
    Shukla, N. K.
    Husain, Syed Akhtar
    [J]. TUMOR BIOLOGY, 2014, 35 (05) : 4517 - 4527
  • [22] Prevalence of common mutations in the CYP17A1 gene in Chinese Han population
    Bao, Xunna
    Ding, Hu
    Xu, Yujun
    Cui, Guanglin
    He, Yebing
    Yu, Xuefeng
    Wang, Dao Wen
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (13-14) : 1240 - 1243
  • [23] Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population
    Wang, Menglin
    Wang, Hao
    Zhao, Haiying
    Li, Ling
    Liu, Min
    Liu, Fujia
    Meng, Fansen
    Fan, Caini
    [J]. CLINICAL HYPERTENSION, 2019, 25 (01)
  • [24] The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis
    Xing, Chuan
    Zhao, Han
    Zhang, Jiaqi
    He, Bing
    [J]. FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [25] Prevalence of CYP17A1 gene mutations in 17α-hydroxylase deficiency in the Chinese Han population
    Menglin Wang
    Hao Wang
    Haiying Zhao
    Ling Li
    Min Liu
    Fujia Liu
    Fansen Meng
    Caini Fan
    [J]. Clinical Hypertension, 25
  • [26] Genetic polymorphisms of the CYP19A1 gene and breast cancer survival
    Long, Ji-Rong
    Kataoka, Nobuhiko
    Shu, Xiao-Ou
    Wen, Wanqing
    Gao, Yu-Tang
    Cai, Qiuyin
    Zheng, Wei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2115 - 2122
  • [27] A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer
    Hopper, JL
    Hayes, VM
    Spurdle, AB
    Chenevix-Trench, G
    Jenkins, MA
    Milne, RL
    Dite, GS
    Tesoriero, AA
    McCredie, MRE
    Giles, GG
    Southey, MC
    [J]. HUMAN MUTATION, 2005, 26 (04) : 298 - 302
  • [28] Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk
    He, Heng
    Deng, Yao
    Wan, Hao
    Shen, Na
    Li, Jiaoyuan
    Zeng, Qiang
    Chang, Jiang
    Lu, Qing
    Miao, Xiaoping
    Tian, Jianbo
    Zhong, Rong
    [J]. CHEMOSPHERE, 2022, 286
  • [29] Haplotype analyses of CYP17A1 genetic polymorphisms and coronary artery disease in a Uygur population
    Dai, Chuan-Fang
    Xie, Xiang
    Ma, Yi-Tong
    Yang, Yi-Ning
    Li, Xiao-Mei
    Fu, Zhen-Yan
    Liu, Fen
    Chen, Bang-Dang
    Gai, Min-Tao
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (02) : 389 - 398
  • [30] The roles of leptin and LEP and LEPR gene polymorphisms in pathogenesis of breast cancer
    Knula, Hanna
    Rubis, Blazej
    Rybczynska, Maria
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (06): : 287 - 291